News Brief
India Engages In Quiet Covaxin Diplomacy; Likely To Get Approval In Several More Countries In Next Two Months
Swarajya Staff
Jul 05, 2021, 06:07 PM | Updated 06:07 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
In a significant boost for the approval of India's home-grown Covid-19 vaccine, Covaxin, the central government is reportedly engaged in quiet diplomacy to assist Bharat Biotech's vaccine to get an international nod.
Notably, Covaxin has already been approved by around 15 countries around the world, and the said move may result in approvals for the vaccine by several countries during July-August.
The report further added that, unlike China, India is engaged in quiet diplomacy. The Centre has advised Bharat Biotech on navigating the complex world of geo-economics transparently and through submission of data at global institutions and various world capitals.
Hyderabad-based Bharat Biotech India Ltd recently publicised the long-awaited results of the Phase-3 trial of Covaxin. The trial involved nearly 25,800 volunteers spanning 25 hospitals across India. It showcased 93.4 per cent effectiveness against severe COVID-19 disease, as per the results of the Phase-3 test.
Bharat Biotech has applied for regulatory approvals in more than 50 countries and emergency use listing with WHO Geneva.
"Bharat Biotech has now received approvals from more than 15 countries, with approvals from several additional countries to be received during July-August 2021. Now that results from Phase-III final analysis have been published, more countries from Asia, Africa, Latin America, Europe and North America have come forward to grant EUAs for Covaxin," the person quoted a person familiar with the development.
"During such a devastating pandemic it is morally and ethically reprehensible that countries place arbitrary and unilateral restrictions on travel. It is extremely important that countries mutually accept regulatory systems and medicinal products to encourage a quicker return to normalcy and restoration of lives and livelihoods. During the early days of the pandemic, several categories of medicines manufactured in India were accepted by countries worldwide, a similar note of reciprocity is the need of the hour," pointed out a source.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.